论文部分内容阅读
食管癌的发病率和死亡率在世界各国差异很大，在中国仍居高不下。新近完成的随机维生素补充试验在中国高发区有降低发病趋势。外科切除是食管癌治疗的主要手段。综合治疗（尤其是术前新辅助治疗）正在临床试验之中。食管癌的切除率达58％－92％，并发症发生率在63％一叨．5％，
The incidence and mortality of esophageal cancer vary greatly among countries in the world and remain high in China. The newly completed random vitamin supplementation trial has a tendency to reduce the incidence in high-incidence areas in China. Surgical resection is the main method for the treatment of esophageal cancer. Comprehensive treatment (especially preoperative neoadjuvant treatment) is in clinical trials. Esophageal cancer resection rate of 58% -92%, the incidence of complications at a rate of 63%. 5%,